← FDA Drug Approvals (Drugs@FDA)

BIMATOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2020-09-08

Drug application

FDA Application #
ANDA202505
Application type
Abbreviated New Drug Application (Generic)
Brand name
BIMATOPROST
Generic name
BIMATOPROST
Active ingredients
BIMATOPROST
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Prescription
Sponsor
MICRO LABS
Manufacturer
Micro Labs Limited
First approval
2020-09-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown